News-CDMO
Appointment to the Board of Directors of Alzprotect (Lille, December 5, 2024).
Dr Philippe Verwaerde (CEO of Alzprotect) announced the appointment of Prof. Christian Bailly (#Oncowitan) to the Board of Directors of Alzprotect (Lille, France) to contribute to the development of their drug candidate AZP2006 (Ezeprogind) for the treatment of progressive supranuclear palsy (PSP).
News-CDMO
Prix Michel Delalande 2023 – Académie nationale de Pharmacie (Paris, December 13, 2023).
Christian Bailly (#Oncowitan) received the Prize Michel Delalande 2023, from the National Academy of Pharmacy (Paris, France) on December 13, 2023. A prize awarded for his research activities on anticancer natural products over the past 30 years.
